← Back to Search
Principals Of Neovascularization For Tissue Engineering.
M. Nomi, A. Atala, P. Coppi, S. Soker
Published 2002 · Medicine, Biology
Download PDFAnalyze on Scholarcy
The goals in tissue engineering include the replacement of damaged, injured or missing body tissues with biological compatible substitutes such as bioengineered tissues. However, due to an initial mass loss after implantation, improved vascularization of the regenerated tissue is essential. Recent advances in understanding the process of blood vessel growth has offered significant tools for therapeutic neovascularization. Several angiogenic growth factors including vascular endothelial cell growth factor (VEGF) and basic fibroblast growth factor (bFGF) were used for vascularization of ischemic tissues. Three approaches have been used for vascularization of bioengineered tissue: incorporation of angiogenic factors in the bioengineered tissue, seeding endothelial cells with other cell types and prevascularization of matrices prior to cell seeding. This paper reviews the process of blood vessel growth and tissue vascularization, and discuss strategies for efficient vascularization of engineered tissues.
This paper references
Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells*
J. Gratton (2001)
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
T. Sato (1995)
Scatter factor/hepatocyte growth factor is essential for liver development
C. Schmidt (1995)
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
C. de Vries (1992)
Angiogenesis and angiogenesis inhibition: an overview.
J. Folkman (1997)
Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor
M. Young (2004)
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada.
J. Tu (1997)
Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
R. Laham (1999)
The angiopoietins: Yin and Yang in angiogenesis.
S. Davis (1999)
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.
L. Naldini (1991)
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
P. Carmeliet (1996)
Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.
W. Murphy (2000)
Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.
B. Schumacher (1998)
VEGF/VPF: The angiogenesis factor found?
M. Klagsbrun (1993)
Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis.
J. Isner (1998)
Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.
E. Gherardi (1991)
Mechanisms of angiogenesis
W. Risau (1997)
Scatter factor induces blood vessel formation in vivo.
D. Grant (1993)
The FGF family of growth factors and oncogenes.
C. Basilico (1992)
Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture.
A. Morimoto (1991)
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*)
A. Levy (1995)
Neuropilin in the midst of cell migration and retraction.
S. Soker (2001)
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
S. Takeshita (1994)
Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells
S. Rogelj (1989)
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
Jun Yamashita (2000)
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
É. Van Belle (1998)
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
T. Joki (2001)
Biological roles of fibroblast growth factor-2.
A. Bikfalvi (1997)
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
A. Yayon (1991)
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.
T. Asahara (1996)
Proteolytic activation of hepatocyte growth factor in response to tissue injury.
K. Miyazawa (1994)
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
J. Park (1993)
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
D. Hanahan (1996)
The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*)
B. Keyt (1996)
Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function
K. Matsumoto (2001)
Systems for therapeutic angiogenesis in tissue engineering
S. Soker (2000)
Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor Vasculature
J. Grunstein (2000)
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.
C. Bauters (1995)
Human Endothelial Cell Life Extension by Telomerase Expression*
J. Yang (1999)
Molecular and biological properties of vascular endothelial growth factor
N. Ferrara (1999)
Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.
M. Mahoney (1999)
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.
T. Asahara (1999)
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia (*)
A. Levy (1996)
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
G. Fong (1995)
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
N. Ferrara (1996)
Blood Vessel Formation: What Is Its Molecular Basis?
J. Folkman (1996)
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
Tomono Takahashi (1999)
Transplantation of hepatocytes using porous, biodegradable sponges.
D. Mooney (1994)
VEGFs, receptors and angiogenesis.
T. Veikkola (1999)
Signaling Vascular Morphogenesis and Maintenance
D. Hanahan (1997)
Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
K. Plate (1993)
CELL TRANSPLANTATION OF GENETICALLY ALTERED CELLS ON BIODEGRADABLE POLYMER SCAFFOLDS IN SYNGENEIC RATS
J. Gilbert (1993)
Polymeric system for dual growth factor delivery
T. P. Richardson (2001)
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
E. Battegay (2004)
PLATELET-DERIVED GROWTH FACTOR
R. Ross (1989)
DNA delivery from polymer matrices for tissue engineering
L. Shea (1999)
Telomerized human microvasculature is functional in vivo
Jiwei Yang (2001)
Controlled and modulated release of basic fibroblast growth factor.
E. Edelman (1991)
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
D. Shweiki (1992)
Peptide Growth Factors and Their Receptors I
新井 健一 (1991)
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo
S. Kaushal (2001)
Inflammation: Basic Principles and Clinical Correlates
J. Gallin (1992)
Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.
J. Abraham (1986)
In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse.
J. Schechner (2000)
Morphogenesis of the First Blood Vessels
C. Drake (1998)
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
S. Soker (1998)
Prevascularization of porous biodegradable polymers
A. Mikos (1993)
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
J. Isner (1996)
Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein*
A. Levy (1996)
Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon
T. Eto (1999)
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
P. Carmeliet (1999)
Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease
A. Rivard (1998)
J. Folkman (2001)
Molecular cloning of murine FLT and FLT4.
H. Finnerty (1993)
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.
S. Takeshita (1996)
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
F. Bussolino (1992)
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels
H. Dvorak (1991)
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
F. Shalaby (1995)
A completely biological tissue-engineered human blood vessel.
N. L'heureux (1998)
VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells
T. Asahara (1999)
Blood vessel maturation: vascular development comes of age.
D. Darland (1999)
Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable.
R. Furlong (1991)
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
K. Houck (1992)
Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy
A. P. Adamis (1994)
Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor.
W. Burgess (1986)
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
D. Shweiki (1993)
Developmental biology: One cell, two fates
P. Carmeliet (2000)
A blood vessel model constructed from collagen and cultured vascular cells.
C. B. Weinberg (1986)
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
H. Dvorak (1995)
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
S. Frank (1995)
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Y. Uehara (1995)
Functional arteries grown in vitro.
L. Niklason (1999)
Vascular permeability factor, an endothelial cell mitogen related to PDGF.
P. J. Keck (1989)
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
T. Asahara (1997)
Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor.
R. Baffour (1992)
Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs.
M. Fontaine (1995)
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.
J. Nör (1999)
In Vitro Models of Vasculogenesis and Angiogenesis
B. Vailhé (2001)
Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*)
S. Soker (1996)
Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.
M. Pepper (1997)
Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice.
I. Ajioka (2001)
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
R. Montesano (1991)
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.
A. Yanagisawa-Miwa (1992)
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
C. Kalka (2000)
Tissue engineering from Adam to the zygote: historical reflections
D. Schultheiss (2000)
The cellular and molecular mechanisms of diabetic complications.
G. King (1996)
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
B. Terman (1992)
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.
G. Breier (1992)
Varicose veins and telangiectasias
S. Darke (1994)
Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.
G. Schatteman (2000)
Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.
W. Jiang (1997)
Vascular-specific growth factors and blood vessel formation
G. Yancopoulos (2000)
The role of angiogenesis in tumor growth.
J. Folkman (1992)
Molecular cloning and expression of human hepatocyte growth factor
T. Nakamura (1989)
VEGF gene delivery to muscle: potential role for vasculogenesis in adults.
M. Springer (1998)
T. Henry (1999)
Induction of Pancreatic Differentiation by Signals from Blood Vessels
E. Lammert (2001)
Engineering and Characterization of Functional Human Microvessels in Immunodeficient Mice
J. Nör (2001)
Long‐term results of femorotibial bypass with vein or polytetrafluoroethylene
R. Sayers (1998)
Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border
G. Yancopoulos (1998)
Molecular mechanisms of vasculogenesis and embryonic angiogenesis
I. Flamme (1997)
Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen
D. Shima (1995)
Therapeutic angiogenesis for heart failure
J. Isner (1999)
Role of vascular endothelial growth factor in regulation of physiological angiogenesis.
N. Ferrara (2001)
Growing better blood vessels
P. Carmeliet (2001)
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
M. Shibuya (1990)
A dual receptor system is required for basic fibroblast growth factor activity
M. Klagsbrun (1991)
Interactions between scatter factors and their receptors: hints for therapeutic applications
L. Trusolino (1998)
Development of Technologies Aiding Large‐Tissue Engineering
P. Eiselt (1998)
Growing new organs.
D. Mooney (1999)
Structure and function of hepatocyte growth factor.
T. Nakamura (1991)
This paper is referenced by
Regenerative Medicine: Past and Present
A. Atala (2009)
Changing concepts of bladder regeneration
A. Kanematsu (2007)
Polymer Modifications and Recent Technological Advances toward Live Cell Encapsulation and Delivery
Paulomi Ghosh (2015)
Vascularization of engineered cartilage constructs in a mouse model
M. Burghartz (2014)
Small molecule inducers of angiogenesis for tissue engineering.
Kristen A. Wieghaus (2006)
Advances in tissue engineering.
S. Levenberg (2004)
Novel microspheres for prolonged cell survival
S. M. Ng (2012)
Analysis of Fat Graft Metabolic Adaptation and Vascularization Using Positron Emission Tomography–Computed Tomographic Imaging
Tomi V. Tervala (2014)
Endothelial Differentiation of Mesenchymal Stromal Cells
Karolina Janeczek Portalska (2012)
Hypoxia-mimicking Co doped TiO2 microporous coating on titanium with enhanced angiogenic and osteogenic activities.
Jianhong Zhou (2016)
Stem Cell-Mediated Angiogenesis in Tissue Engineering Constructs.
N. Kiaie (2019)
Harnessing Macrophages for Vascularization in Tissue Engineering
Erika M Moore (2018)
Engineering hydrogels as extracellular matrix mimics.
Hikmet Geçkil (2010)
Flow-Induced Vascular Network Formation and Maturation in Three-Dimensional Engineered Tissue
B. Zohar (2017)
Microfabrication of Capillary System Using a Perfusion Cell Chamber
A. Migliore (2007)
Oxygen producing biomaterials for tissue regeneration.
B. Harrison (2007)
Reversible mitotic and metabolic inhibition following the encapsulation of fibroblasts in alginate hydrogels.
N. Hunt (2009)
Cells for musculoskeletal tissue engineering
K. Kong (2015)
Use of Mesothelial Cells and Biological Matrices for Tissue Engineering of Simple Epithelium Surrogates
C. C. Lachaud (2015)
Tissue Engineering to Improve Immature Testicular Tissue and Cell Transplantation Outcomes: One Step Closer to Fertility Restoration for Prepubertal Boys Exposed to Gonadotoxic Treatments
Federico Del Vento (2018)
[Biological vascularized matrix (BioVaM): a new method for solving the perfusion problems in tissue engineering].
D. Schultheiss (2004)
Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation.
M. Youssif (2005)
VEGF profiling and angiogenesis in human microtissues.
J. Kelm (2005)
Non-destructive real-time imaging of cell morphology for tissue-engineering applications
M. Hofmann (2011)
Biocompatibility studies of endothelial cells on a novel calcium phosphate/SiO2-xerogel composite for bone tissue engineering.
Benjamin W. Thimm (2008)
Mechanobiological Modelling of Angiogenesis: Impact on Tissue Engineering and Bone Regeneration
E. Reina-Romo (2011)
VEGF Microsphere Technology to Enhance Vascularization in Fat Grafting
Christopher W. Chung (2012)
Endothelial Differentiation of Human Stem Cells Seeded onto Electrospun Polyhydroxybutyrate/Polyhydroxybutyrate-Co-Hydroxyvalerate Fiber Mesh
A. Zonari (2012)
Bladder Acellular Matrix and Its Application in Bladder Augmentation
HYALURONAN BASED BIOMATERIALS FOR CENTRAL NERVOUS TISSUE REGENERATION
Baiget Orts (2012)
Long‐bone critical‐size defects treated with tissue‐engineered grafts: A study on sheep
V. Viateau (2007)
In vitro and in vivo evaluation of acellular diaphragmatic matrices seeded with muscle precursors cells and coated with VEGF silica gels to repair muscle defect of the diaphragm.
M. Conconi (2009)See more